Evidence map›Paper›PMID 41279304›Full record

ArticlebioRxiv : the preprint server for biology2025

Nano-Mod-Amp reveals RNA sequence, structural and cell type specific features of pseudouridylation by PUS7.

Rebecca Rodell, Ronit Jain, Hossein Shenasa, Matias Montes, Nicolas Robalin, Stefan Prodic, Eduardo Eyras, Nicole M Martinez

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Rebecca RodellDepartment of Chemical and Systems, Stanford University, Stanford, CA 94305.ORCID 0000-0002-6034-0889
Ronit JainDepartment of Chemical and Systems, Stanford University, Stanford, CA 94305.
Hossein ShenasaDepartment of Chemical and Systems, Stanford University, Stanford, CA 94305.ORCID 0000-0003-0765-6638
Matias MontesDepartment of Chemical and Systems, Stanford University, Stanford, CA 94305.ORCID 0000-0003-3637-6379
Nicolas RobalinDepartment of Chemistry, Stanford University, Stanford, CA 94305.ORCID 0000-0001-6359-609X
Stefan ProdicEMBL Australia Partner Laboratory Network, the Australian National University, Canberra, ACT 2601, Australia.
Eduardo EyrasEMBL Australia Partner Laboratory Network, the Australian National University, Canberra, ACT 2601, Australia.ORCID 0000-0003-0793-6218
Nicole M MartinezDepartment of Chemical and Systems, Stanford University, Stanford, CA 94305.ORCID 0000-0001-9579-703X

Funding

Molecular Pharmacology Training ProgramT32GM136631 · NIGMS · STANFORD UNIVERSITY · PI BOGYO, MATTHEW, CHEN, JAMES K · 2021 to 2025
$2.0M
Role of pseudouridines in pre-mRNA processingR00GM135537 · NIGMS · STANFORD UNIVERSITY · PI MARTINEZ, NICOLE · 2022 to 2024
$747k
NIGMS NIH HHS R00 GM135537NIGMS NIH HHS T32 GM136631
6 · The paper itself

Abstract

Pseudouridines are abundant mRNA modifications that can impact splicing, translation, and stability to tune gene expression. PUS7 is one of the major mRNA pseudouridine synthase whose dysregulation leads to neurodevelopmental disorders and cancer, underscoring the critical function of PUS7-dependent pseudouridines. Beyond a short and degenerate consensus sequence, the molecular mechanisms underlying PUS7-mediated pseudouridylation remain unknown. A lack of targeted, high-throughput pseudouridine detection methods limits simultaneous interrogation of PUS7 regulatory features across many experimental conditions. We developed novel Nanopore sequencing tools, including Nano-Mod-Amp, to reveal pseudouridine stoichiometry, its RNA structural context, and dependence on PUS7 levels at specific sites across biological conditions. We identified a novel RNA structural signature that is associated with more efficient mRNA modification by PUS7. Pseudouridines are largely responsive to modulations in PUS7 protein levels, demonstrating the regulatory potential of varying PUS7 levels across cellular conditions. Conversely, PUS7 activity is also regulated in a cell-type specific manner, independent of PUS7 expression levels in a manner consistent with regulation by RNA structure and RNA binding proteins. Together, we developed Nanopore sequencing tools and uncovered new mechanisms of PUS7 regulation with a framework that can be applied to other RNA-modifying enzymes to query the regulation of the epitranscriptome.

Identifiers

PMID41279304
PMCPMC12636312

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.